Evaluation of the Relationship Between Clinical Features of Acrochordons and Metabolic Syndrome Components: Prospective Cross-Sectional Study Akrokordonların Klinik Özelikleri ile Metabolik Sendrom Komponentlerinin İlişkisinin Değerlendirilmesi: Prospektif Kesitsel Çalışma

Creative Commons License

KOÇ YILDIRIM S., ERBAĞCI E., DEMİREL ÖĞÜT N.

Turkiye Klinikleri Dermatoloji, cilt.36, sa.1, ss.8-14, 2026 (Scopus)

Özet

Objective: The aim of this study is to assess the metabolic syndrome components in patients with acrochordons. Material and Methods: A total of 53 patients were included to this prospective cross-sectional designed study. Demographics, characteristics of acrochordons, body mass index (BMI), waist circumference, blood pressure, fasting blood glucose and lipid parameters were recorded. Results: The mean acrochordon count was 28.77±23.009 (minimum: 3, maximum: 105). 62.3% (n=33) of the patients had pigmented acrochordons. The most common localization of acrochordons was neck (n=52, 98.8%). The mean BMI was 32.54±5.073. 67.9% (n=36) of the patients were obese and 28.3% (n=15) of the patients were overweight. 33.9% (n=18) of the patients had hypertension, %49 (n=26) of the patients had impaired fasting glucose or diabetes mellitus, 73.6% (n=39) of the patients had dyslipidemia and 58.5% (n=31) of the patients were diagnosed as metabolic syndrome. There was a low correlation between total acrochordon count and BMI (p=0.043; r=0.279) and a moderate correlation with systolic blood pressure (p=0.04, r=0.385). When we categorized the total acrochordon count as ≤10 and >10; there was a statistically significant difference between the presence of hypertension and pre-diabetes/diabetes (p=0.04 and 0.04, respectively). The presence of hypertension and metabolic syndrome was found to be significantly higher in those with pigmented acrochordon than in those without it (p=0.001 and 0.01, respectively). Conclusion: Further evaluation may be necessary for those with >10 acrochordons, especially in terms of hypertension and pre-diabetes/diabetes, and for hypertension and metabolic syndrome in those with pigmented acrochordons.